Health Care/Hospital
Nordic Bioscience to make its precision medicine biomarker PRO-C3 available in China for research use only (RUO) in the first quarter of 2024.
HERLEV, Denmark, Feb. 6, 2024 /PRNewswire/ -- Nordic Bioscience, a leading biomarker company, today announced that the company's extracellular matrix (ECM) biomarker, PRO-C3 (nordicPRO-C3™) will be available as a research use only (RUO) product inChina at LabCorp. All testing outside China contin...
2024-02-06 06:30
1364
TraceLink's 2023 Success: Expanded Digitalization Capabilities and Growing Adoption of New Supply Chain Solutions
BOSTON, Feb. 6, 2024 /PRNewswire/ -- TraceLink, the world's largest digital network platform for healthcare and life sciences, expanded its digitalization capabilities in 2023, leading to an annual increase of more than 300 new customers. Utilizing the industry's largest integrated digital networ...
2024-02-06 04:50
1225
Rokit Healthcare Scores High Marks in KOSDAQ Tech Listing Evaluation
SEOUL, South Korea, Feb. 5, 2024 /PRNewswire/ -- Rokit Healthcare, a trailblazer in AI-driven medical bioprinting technology, proudly announces its achievement of an AA rating in the KOSDAQ (Korea Securities Dealers Automated Quotations) technology listing evaluation. Garnering A grades from both...
2024-02-05 22:00
1313
Deep Sleep in 10 minutes: MOZA Launches the Sleepris Eye Massager to Induce Better Sleep and Reduce Stress
IRVINE, Calif. , Feb. 5, 2024 /PRNewswire/ -- MOZA Technology ("MOZA'' or "the Company"), a pioneer in mindfulness and relaxation technology, has launched Sleepris, the first smart eye massager designed for comfortable all-night wear. Designed to alleviate insomnia, prevent sleep loss and reduce ...
2024-02-05 22:00
1601
Genesis MedTech Completes Enrollment in its United States Early Feasibility Study Utilizing the J-Valve™ Transfemoral System for Patients with Severe Aortic Regurgitation
JC Medical reports milestone accomplishment with its TAVR device BURLINGAME, Calif., Feb. 5, 2024 /PRNewswire/ -- Genesis MedTech, a leading medical device company, today announced the completion of enrollment in its United States Early Feasibility Study (EFS) using its dedicated transcatheter ...
2024-02-05 22:00
1149
BrainGear Develops SleePYA, the Digital Healthcare for Brain Rehabilitation and Sleep Aid
SEOUL, South Korea, Feb. 5, 2024 /PRNewswire/ -- As startup engaging in digital
healthcare business, especially brain rehabilitation and sleep aid, BrainGear
has developed SleePYA with infrared light to stimulate the brain to induce
quality of sleep.
2024-02-05 22:00
1226
Technoderma Medicines Phase 2 Clinical Trial of TDM-105795 Demonstrates Hair Growth in Androgenetic Alopecia
CHENGDU, China, Feb. 5, 2024 /PRNewswire/ -- Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report that the Company has completed its Phase 2a clinical trial (NCT05802173) of TDM-105795 topical solution for Androgenetic Alopecia (AGA). This ...
2024-02-05 21:00
1315
NouvNeu001 Achieves Milestone with Successful Dosing of First Patient, Signaling Smooth Progress in iRegene Therapeutics' Multicenter Clinical Trial for Innovative Novel Parkinson's Disease Therapy
WUHAN, China, Feb. 5, 2024 /PRNewswire/ -- iRegene Therapeutics Co., Ltd (iRegene) recently announced that NouvNeu001, the company's first innovative product, has completed the dosing for its first patient at Beijing Hospital, and the patient has also successfully concluded the observation period...
2024-02-05 21:00
1407
International Human Frontier Science Program Organization Releases 2024-2032 Strategic Plan: "Frontier Life Science in a Time of Change"
STRASBOURG, France, Feb. 5, 2024 /PRNewswire/ -- The International Human Frontier Science Program Organization (HFSPO) issued today its new, nine-year strategic plan which will greatly enhance Research Grant and Fellowship award programs and implement new initiatives to extend opportunities to mo...
2024-02-05 21:00
1346
Venus Medtech VenusP-Valve transcatheter pulmonic valve replacement system granted Health Canada approval
HANGZHOU, China, Feb. 5, 2024 /PRNewswire/ -- Venus Medtech (02500. HK), a leading provider of integrated solutions for transcatheter structural heart valvular therapies inChina, announced today that, VenusP-Valve, the company's in-house developed innovative transcatheter pulmonic valve replaceme...
2024-02-05 21:00
1650
Personnel changes in the Exyte management: Mark Garvey and Elena Bashkeeva are welcomed as new members of the Executive Board
* High-tech industry expert Mark Garvey is new Segment CEO for Exyte's Global Business Unit Advanced Technology Facilities * Elena Bashkeeva will become CFO at Exyte starting April 1st 2024 and will lead the Finance and Controlling functions as well as IT STUTTGART, Germany, Feb. 5, 2024 /PRN...
2024-02-05 20:00
1389
Luye Pharma Grants Myung In Pharm Exclusive Rights to Commercialize Rivastigmine Twice Weekly Transdermal Patch in South Korea
YANTAI, China, Feb. 5, 2024 /PRNewswire/ -- Luye Pharma Group has entered into an agreement with Myung In Pharm, granting the latter the exclusive rights to commercialize Rivastigmine Twice Weekly Transdermal Patch inSouth Korea. Developed by Luye Pharma, this drug is used to treat mild to modera...
2024-02-05 18:53
1700
Hettigoda Industries Private Limited's Siddhalepa Liv-Pro Gains Recognition at the International Innovation Awards 2023
SINGAPORE, Feb. 5, 2024 /PRNewswire/ -- Hettigoda Industries Private Limited's Siddhalepa Liv-Pro, an Ayurvedic food supplement formulated with herbs, garnered acclaim at the International Innovational Awards (IIA) 2023 inTaipei, Taiwan. As an integral pillar of the Innovation Revolution movement...
2024-02-05 18:02
1265
CARiNG Pharmacy Awarded Gold in Esteemed Putra Aria Brand Awards 2023 in Retail Category
KUALA LUMPUR, Malaysia, Feb. 5, 2024 /PRNewswire/ -- CARiNG Pharmacy proudly announced its victory at the second edition of the prestigious Putra Aria Brand Awards 2023, securing the coveted Gold Award in the Retail Category in recognition of its outstanding contributions to the retail industry. ...
2024-02-05 17:31
1262
Celebrating a Legacy of Care - Pantai Hospital Kuala Lumpur Celebrates 50 Years of Excellence in Healthcare and Unveils Its Future Vision with Gala Dinner
KUALA LUMPUR, Malaysia, Feb. 5, 2024 /PRNewswire/ -- Pantai Hospital Kuala
Lumpur (PHKL) marked a significant milestone with its 50th Anniversary Gala
Dinner, an event that highlighted the hospital's impressive legacy and future
ambitions in the healthcare sector.
2024-02-05 17:01
1613
Wingderm® "Dual Innovation, Infinite Possibilities" Global Distributor conference was successfully held at IMCAS
BEIJING, Feb. 5, 2024 /PRNewswire/ -- IMCAS World Congress 2024 was held in Paris, France from February 1st to 3rd. On the first day, Wingderm® successfully held the "Dual Innovation, Infinite Possibilities" new device release conference for its signed distributors worldwide, along with Renuva® ...
2024-02-05 16:50
1101
Innovent Announces Retirement of CFO and Appointment of New CFO
ROCKVILLE, Md. and SUZHOU, China, Feb. 5, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("c") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other ...
2024-02-05 16:45
2411
Singapore Bio-Tech Company Bio Ark Global Partners Bandung's State-Owned Enterprise, Signs MOU To Be Awarded 4000ha Of Land In Pemalang
~ Redefining Agriculture is Bio Ark Global's Vision for Indonesia ~
SINGAPORE, Feb. 5, 2024 /PRNewswire/ -- Bio Ark Global Pte Ltd
2024-02-05 15:12
1236
Agilis Robotics Unveils Groundbreaking Advancements in Endoluminal Surgery
HONG KONG, Feb. 2, 2024 /PRNewswire/ -- Agilis Robotics, a leading innovator in surgical robotics, is spearheading a paradigm shift in the field of "incisionless" endoluminal surgery. The company has made remarkable technological breakthroughs in developing highly miniaturized and flexible robot...
2024-02-05 09:53
1482
Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE2016, a First-in-Class Allogeneic Anti-EGFR Cell Therapy
* ACE2016 Is an Allogeneic Gamma Delta 2 (γδ2) T Cell Therapy Targeting the Epidermal Growth Factor Receptor (EGFR) in Patients With Solid Tumors. * Phase 1 Clinical Study Expected to Begin in H2 2024. ALAMEDA, Calif. and TAIPEI, Feb. 4, 2024 /PRNewswire/ -- Acepodia (6976:TT), a clinical stag...
2024-02-05 08:00
1222
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 273 media titles]
2024-04-24 17:09
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
5790
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
2024-04-22 16:00
4447
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
2024-04-22 06:00
4039
TCTM Filed 2023 Annual Report on Form 20-F
2024-04-20 05:48
3320
Dingdong Files Its Annual Report on Form 20-F
2024-04-20 05:00
3064